151 related articles for article (PubMed ID: 9474248)
21. [Malignant lymphoma].
Hirano M
Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):363-7. PubMed ID: 7525807
[No Abstract] [Full Text] [Related]
22. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
[TBL] [Abstract][Full Text] [Related]
23. A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
Bower M; Brock C; Gulliford T; O'Reilly SM; Smith DB; Newlands ES
Cancer Chemother Pharmacol; 1996; 38(1):106-9. PubMed ID: 8603443
[TBL] [Abstract][Full Text] [Related]
24. [Primary non-Hodgkin's lymphoma of paranasal sinuses. Review of the literature and a case report].
Bianconcini G; Mazzali F; Candini R; Dallasta A; Gobbi F
Minerva Med; 1992 Oct; 83(10):653-61. PubMed ID: 1281296
[TBL] [Abstract][Full Text] [Related]
25. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
Baldini L; Guffanti A; Gobbi P; Colombi M; Federico M; Avanzini P; Cavanna L; Pieresca C; Silingardi V; Maiolo AT
Cancer; 1997 Mar; 79(6):1234-40. PubMed ID: 9070503
[TBL] [Abstract][Full Text] [Related]
26. A Demyelinating Disease; What Lies Beneath?
Rabah F; Elmanzalawy A; Bhuyan D; El-Banna N; Beshlawi I
Indian J Pediatr; 2016 Apr; 83(4):365-7. PubMed ID: 26204979
[No Abstract] [Full Text] [Related]
27. Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
Palmieri G; Morabito A; Rea A; Biondi E; Lauria R; Matano E; Pagliarulo C; Montesarchio V; Tagliaferri P; Bianco AR
Int J Oncol; 1998 Jul; 13(1):121-7. PubMed ID: 9625813
[TBL] [Abstract][Full Text] [Related]
28. Challenges in the management of Burkitt's lymphoma.
Levine AM
Clin Lymphoma; 2002 Dec; 3 Suppl 1():S19-25. PubMed ID: 12521385
[TBL] [Abstract][Full Text] [Related]
29. Late-onset meningeal lymphomatosis in mantle cell lymphoma controlled with chemotherapy.
Alonso JJ; Cánovas A; Riñón MM
Neurologia (Engl Ed); 2018 Apr; 33(3):201-202. PubMed ID: 27126565
[No Abstract] [Full Text] [Related]
30. BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
Cortelazzo S; Rossi A; Viero P; Bellavita P; Marchioli R; Marfisi RM; Rambaldi A; Barbui T
Br J Haematol; 1997 Nov; 99(2):379-85. PubMed ID: 9375759
[TBL] [Abstract][Full Text] [Related]
31. Primary lacrimal sac non-Hodgkin's lymphoma in a child.
Köksal Y; Kiratli H; Varan A; Akçören Z; Büyükpamukçu M
Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1551-3. PubMed ID: 16085321
[TBL] [Abstract][Full Text] [Related]
32. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
34. New treatment options have changed the survival of patients with follicular lymphoma.
Fisher RI; LeBlanc M; Press OW; Maloney DG; Unger JM; Miller TP
J Clin Oncol; 2005 Nov; 23(33):8447-52. PubMed ID: 16230674
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
36. Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
Lombardo M; Morabito F; Merli F; Molica S; Cavanna L; Sacchi S; Broglia C; Angrilli F; Ilariucci F; Stelitano C; Luisi D; Bertè R; Luminari S; Federico M; Brugiatelli M;
Leuk Lymphoma; 2002 Sep; 43(9):1795-801. PubMed ID: 12685834
[TBL] [Abstract][Full Text] [Related]
37. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
Gopal R; Nair R; Saikia TK; Soman CS; Dinshaw KA; Advani SH
J Assoc Physicians India; 1994 Oct; 42(10):781-4. PubMed ID: 7533151
[TBL] [Abstract][Full Text] [Related]
38. [Burkitt's lymphoma--a case report].
Obeid L; Schär B; Heitzmann F; Bargetzi M
Praxis (Bern 1994); 1999 Sep; 88(36):1444-8. PubMed ID: 10500420
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.
Olopade OI; Larson RA; Mick R; Watson SM; Hoffman PC; Ultmann JE; Golomb HM
Leukemia; 1990 Feb; 4(2):127-31. PubMed ID: 1689439
[TBL] [Abstract][Full Text] [Related]
40. [Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy].
Montalbán C; Arechaga S; Calleja JL; Bellas C; Patier JL; Berenguer A; García Villanueva A; Marcos Robles J
Med Clin (Barc); 1990 Mar; 94(12):461-4. PubMed ID: 1694944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]